Associated Papers
Molecular and Clinical Profiles of Patients with RASopathies: Targeted Next-Generation Sequencing Panel Results and Identification of 14 Novel Disease-Causing Variants.
Ates K et al.
Molecular Syndromology, 2025
Beyond Structural Bioinformatics for Genomics with Dynamics Characterization of an Expanded KRAS Mutational Landscape.
Ratnasinghe BD et al.
Biorxiv : the Preprint Server for Biology, 2023
Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape.
Ratnasinghe BD et al.
Computational and Structural Biotechnology Journal, 2023
Development of Noonan syndrome by deregulation of allosteric SOS autoactivation.
Umutesi HG et al.
The Journal of Biological Chemistry, 2020
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Mack PC et al.
Cancer, 2020
RASopathy in Patients With Isolated Sagittal Synostosis.
Davis AA et al.
Global Pediatric Health, 2019
Noonan syndrome: lessons learned from genetically modified mouse models.
Schuhmacher AJ et al.
Expert Review of Endocrinology & Metabolism, 2017
The impact of the genetic background in the Noonan syndrome phenotype induced by K-Ras(V14I).
Hernández-Porras I et al.
Rare Diseases (austin, Tex.), 2015
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.
Ahlquist T et al.
Neoplasia (new York, N.y.), 2008
Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM et al.
British Journal of Haematology, 2008
Germline KRAS mutations cause Noonan syndrome.
Schubbert S et al.
Nature Genetics, 2006
Select a paper to view details